Structures by: Joseph A.
Total: 11
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0524(2)Å b=16.3826(5)Å c=23.4238(7)Å
α=90° β=90° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=5.9874(5)Å b=16.1056(15)Å c=23.4443(19)Å
α=90° β=90.04(2)° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0018(6)Å b=16.139(2)Å c=23.448(3)Å
α=90.000(7)° β=90.032(7)° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0587(3)Å b=16.4386(10)Å c=23.3475(14)Å
α=90° β=90° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.1145(2)Å b=17.2901(6)Å c=22.4334(8)Å
α=90° β=90° γ=90°
[Fe(5-Br-salEen)2]ClO4
[Fe(5BrsalEen)2]ClO4
Chem. Sci. (2016) 7, 7 4251
a=10.3027(4)Å b=14.2644(6)Å c=18.1624(7)Å
α=90° β=90° γ=90°
C22H28Br2ClFeN4O6
C22H28Br2ClFeN4O6
Chem. Sci. (2016) 7, 7 4251
a=11.931(3)Å b=12.170(3)Å c=19.166(5)Å
α=90° β=90° γ=90°
C6H7NO4
C6H7NO4
CrystEngComm (2019) 21, 13 2220
a=4.4942(6)Å b=16.396(2)Å c=9.0283(12)Å
α=90° β=89.977(7)° γ=90°
C8H11NO4S
C8H11NO4S
CrystEngComm (2019) 21, 13 2220
a=5.2351(3)Å b=22.4779(13)Å c=8.4174(5)Å
α=90° β=94.301(4)° γ=90°
C8H11NO4S
C8H11NO4S
CrystEngComm (2019) 21, 13 2220
a=5.2638(7)Å b=22.580(3)Å c=8.5353(11)Å
α=90° β=93.269(7)° γ=90°
C6H7NO4
C6H7NO4
CrystEngComm (2019) 21, 13 2220
a=4.50390(10)Å b=16.3890(6)Å c=8.8561(3)Å
α=90° β=91.271(2)° γ=90°